Advancing CIK cell immunotherapy: highlights from the second international conference on DC-CIK and CAR-CIK approaches
Year: 2025
Type: article
Abstract: On April 7, 2025, the 2nd International CIK Cell Conference was held in Monza, Italy, marking the establishment of the International Society for CIK Cells (ISCC). The conference, kindly supported by Fondazione Tettamanti (Italy), featured cutting-edge advancements in cytokine-induced killer (CIK) cell immunotherapy, used alone and in combination with dendritic cells (DC-CIK) and chimeric antigen receptors (CAR-CIK). The event also provided a valuable opportunity for young investigators to engage in insightful discussions and to network within experts in the field.
Source: Cancer Immunology Immunotherapy
Authors: Amit Sharma, Dario Sangiolo, Antonio Rosato, Jingjing Pu, Jian Hou, Sarah Tettamanti, Marta Serafini, Kevin Aaron Fenix, Martino Introna, Alessandro Rambaldi, Xiubao Ren, Ingo G. H. Schmidt-Wolf
Institutions: University Hospital Bonn, University of Turin, University of Padua, Shanghai Jiao Tong University, Renji Hospital, The University of Adelaide, Ospedale Papa Giovanni XXIII, University of Milan, Tianjin Medical University Cancer Institute and Hospital, Istituto Oncologico Veneto, Tianjin Medical University
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $4,590
Funder: Deutsche Krebshilfe
OpenAlex ID: W4415802017